5-amino-1MQ oral dosage is not officially established. Learn what anecdotal protocols report, how oral and injectable routes compare, and the safety gaps.
There is no officially established oral dosage of 5-amino-1MQ for humans. The compound is sold as a research chemical, and the numbers repeated online — usually 100 mg to 150 mg per day — come from anecdotal reports and vendor labels rather than controlled human trials. Those figures should be read as unverified research notes, not medical guidance.
What 5-Amino-1MQ Is and Why It Is Being Studied
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small synthetic molecule that blocks nicotinamide N-methyltransferase, an enzyme known as NNMT. NNMT helps regulate how cells process nicotinamide, a form of vitamin B3 tied to NAD+ metabolism and overall energy balance.
Interest in the compound grew after preclinical mouse studies linked NNMT inhibition to lower fat mass, better glucose handling, and shifts in metabolic markers. Those findings come from animals, and animal results frequently fail to translate into human outcomes.
5-Amino-1MQ has never been approved by the FDA for human use, and no regulatory agency has established a safe or effective oral dose.
What Anecdotal Oral Protocols Report
Because no clinical dosing data exists, every number in circulation traces back to forums, vendor labels, and self-reported logs. Those sources cluster in a fairly narrow band.
| Route | Commonly cited amount | Frequency | Evidence behind it |
|---|---|---|---|
| Oral capsule or liquid | 100–150 mg | Once daily | Anecdotal only |
| Subcutaneous injection | 10–20 mg | Once daily | Anecdotal only |
| Clinical trial dose | None established | Not applicable | No human data |
Most threads that mention the 5-amino-1mq dosage per day settle on 100 mg to 150 mg taken once, a figure that no clinical trial has verified. Some users describe starting lower and increasing over several weeks — a pattern borrowed from other research compounds rather than from any 5-amino-1MQ-specific study.
Oral vs. Injectable Dosing
Side-by-side comparisons of 5-amino-1mq oral vs injection dosage usually show a wide gap. Reported oral amounts run five to ten times higher than reported injected amounts, which suggests users assume the oral route absorbs poorly.
That assumption is reasonable but unproven. Human oral bioavailability of 5-amino-1MQ has never been published, so nobody can say how much of a capsule actually reaches the bloodstream or how long it remains active.
Curiosity about 5-amino-1mq dosage subcutaneous protocols reflects the same assumption: injections are thought to require far less compound. Injecting an unregulated powder still carries risks that swallowing a capsule does not, including sterility problems, dosing errors, and injection-site reactions.
| Factor | Oral | Subcutaneous |
|---|---|---|
| Convenience | High — no needles or mixing | Lower — needs supplies and technique |
| Reported amount | 100–150 mg per day | 10–20 mg per day |
| Measured bioavailability | Unknown | Unknown |
| Infection risk from the route | Minimal | Present if technique or product is poor |
| Regulatory status | Not approved for human use | Not approved for human use |
Where the Commonly Quoted Numbers Come From
Vendors usually publish a 5-amino-1mq reconstitution and dosage sheet with each vial, and that sheet is the only dosing reference most buyers ever see. These documents are marketing materials rather than study results, and they rarely cite a source.
A typical 5-amino-1mq dosage calculator converts milligrams of powder and milliliters of water into units on an insulin syringe. The arithmetic is usually correct; what the calculator cannot tell you is whether the underlying dose has ever been tested in humans.
Some sellers suggest oral capsules at the same level as injectable protocols, while others list far higher oral amounts. That inconsistency is a sign that nobody is working from measured data.
Timing and Duration in User Reports
Nearly all anecdotal protocols describe a single daily dose, taken either in the morning or before the largest meal of the day. No published research supports one timing over another.
Reported cycle lengths vary widely, from a few weeks to several months, often followed by a break. There is no evidence that cycling reduces risk, and no data at all on what long-term exposure does to the human body.
Stacking is another common theme, with 5-amino-1MQ combined with other metabolic research compounds. Combining unregulated substances multiplies the unknowns rather than resolving them.
Safety, Purity, and Legal Status
Research chemicals sold online are not verified for identity or purity by any regulator, so what is printed on a vial may not match what is inside it.
- No established human dose, no published toxicity profile, and no long-term safety data exist for 5-amino-1MQ.
- Products are typically labeled for research use only and not for human consumption, which shifts all risk to the buyer.
- NNMT influences how the body handles nicotinamide, a nutrient connected to NAD+ metabolism, so unintended interactions are possible but unstudied.
- People who take prescription medication, are pregnant, or manage a chronic condition face additional unknown risk.
Because none of these questions have reliable answers yet, a licensed physician or pharmacist is the right person to consult before considering any dose, oral or otherwise.
The Bottom Line on 5-Amino-1MQ Oral Dosage
No verified 5-amino-1MQ oral dosage exists for humans. The frequently repeated range of 100 mg to 150 mg per day is a folklore figure drawn from anecdotal reports, and injected amounts of 10 mg to 20 mg are equally unverified.
If you are researching this compound, treat every published number as a hypothesis rather than a protocol. Human pharmacokinetic studies would be required before any dose could reasonably be called safe, and none have been published.
Frequently Asked Questions
Is there an official 5-amino-1MQ oral dosage for humans?
No. No regulatory agency or peer-reviewed human trial has established a safe or effective oral dose of 5-amino-1MQ. Every number circulating online comes from vendor labels, forums, or self-reported logs rather than controlled research.
How much 5-amino-1MQ do people report taking orally per day?
Anecdotal reports most often cite 100 mg to 150 mg taken once daily, though some users describe lower starting amounts. These figures are not supported by any published human pharmacokinetic data, so they should not be treated as a validated dose.
Is oral 5-amino-1MQ better than injecting it?
There is no evidence that either route is better or safer in humans. Oral use avoids needles and sterility concerns, while injected protocols are reported at much lower amounts, but human bioavailability for both routes remains unmeasured.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.